Oxidative stress in graves' disease.
Increased reactive oxygen species (ROS) generation and the consequent oxidative damage are involved in the development of several diseases, including autoimmune diseases. Graves' disease is an autoimmune disorder characterized by hyperthyroidism and, less frequently, orbitopathy. Hyperthyroidism is characterized by increased oxidative stress. Untreated hyperthyroidism is associated with an increase of several parameters of oxidative stress and in most studies (but not all) by an increase of antioxidant defense enzymes. Restoration of euthyroidism with antithyroid drug is associated with a reversal of the biochemical abnormalities associated with oxidative stress. Animal and human studies suggest that increased ROS may directly contribute to some clinical manifestation of the disease, including orbitopathy. Antioxidants administered alone improve some clinical signs and symptoms of hyperthyroidism and, when associated with antithyroid drugs, induce a more rapid control of clinical manifestations and a faster achievement of euthyroidism. A large randomized clinical trial has shown that antioxidant supplementation (selenium) may also be beneficial for mild Graves' orbitopathy.
Department of Endocrinology and Metabolism, University of Pisa, Pisa, Italy.
Claudio
C
Marcocci
Department of Endocrinology and Metabolism, University of Pisa, Pisa, Italy.
Marenza
M
Leo
Department of Endocrinology and Metabolism, University of Pisa, Pisa, Italy.
Maria Antonietta
MA
Altea
Antithyroid drugs; Graves' orbitopathy; Hyperthyroidism; Selenium